Related Experiment Videos
[Chronic use of analgesics]
Sozial- Und Praventivmedizin
|January 1, 1990
Summary
Regular long-term use of analgesics, particularly mixed compounds with caffeine, significantly increases the risk of developing end-stage renal failure. This study highlights the dangers of frequent pain reliever consumption.
Area of Science:
- Nephrology
- Pharmacology
- Epidemiology
Background:
- Long-term analgesic use is common, but its association with kidney damage requires further investigation.
- End-stage renal failure (ESRF) poses a significant public health challenge.
Purpose of the Study:
- To quantitatively assess the relationship between regular analgesic intake and the risk of developing end-stage renal failure.
- To identify patterns of analgesic consumption associated with renal failure.
Main Methods:
- A case-control study was conducted in West Berlin between 1984 and 1986.
- Investigated lifetime analgesic consumption in over 1000 individuals.
- Defined regular analgesic intake as ≥15 doses/month for ≥12 months.
Main Results:
- 285 long-term analgesic users were identified (185 cases, 100 controls).
- An odds ratio of 2.44 (95% CI: 1.77-3.39) indicated a significantly higher risk of ESRF with regular analgesic use.
- 90% of regular users preferred mixed analgesics, often containing caffeine.
Conclusions:
- Regular, long-term analgesic consumption is a significant risk factor for end-stage renal failure.
- Mixed analgesic compounds, especially those with caffeine, are frequently used by individuals at risk.
- Public health initiatives should address the risks associated with chronic analgesic use.